Cardiac Dimensions Overview

  • Year Founded
  • 2001

Year Founded

  • Status
  • Private

  • Employees
  • 73

Employees

  • Latest Deal Type
  • Series E

  • Latest Deal Amount
  • $53M

  • Investors
  • 21

Cardiac Dimensions General Information

Description

Developer of novel interventional tools designed for the treatment of heart failure and related conditions of mitral valve regurgitation. The company's product is a non-surgical device developed to treat functional mitral valve regurgitation and uses a catheter-based approach to reshape the mitral valve and reduce mitral regurgitation, enabling surgeons to perform minimally invasive treatments to address heart failure and related cardiovascular conditions.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 5540 Lake Washington Boulevard North East
  • Kirkland, WA 98033
  • United States
+1 (425)
Primary Industry
Therapeutic Devices
Other Industries
Other Healthcare Technology Systems
Vertical(s)
Corporate Office
  • 5540 Lake Washington Boulevard North East
  • Kirkland, WA 98033
  • United States
+1 (425)

Cardiac Dimensions Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cardiac Dimensions Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
21. Later Stage VC (Series E) 20-Mar-2025 $53M Completed Generating Revenue
20. Later Stage VC (Series D) 22-Dec-2022 Completed Generating Revenue
19. Later Stage VC 28-Mar-2022 Completed Generating Revenue
18. Later Stage VC (Series C) 28-Sep-2020 Completed Generating Revenue
17. Debt - PPP 28-Apr-2020 Completed Generating Revenue
16. Later Stage VC (Series C) 09-Mar-2020 Completed Generating Revenue
15. Later Stage VC 23-Oct-2018 Completed Generating Revenue
14. Later Stage VC (Series B) 26-Apr-2018 Completed Clinical Trials - General
13. Debt - General 01-Jan-2018 $12M $194M Completed Clinical Trials - General
12. Later Stage VC 29-Sep-2017 $32M $182M Completed Clinical Trials - General
To view Cardiac Dimensions’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Cardiac Dimensions Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of novel interventional tools designed for the treatment of heart failure and related conditions of mitral val
Therapeutic Devices
Kirkland, WA
73 As of 2026

Herzliya, Israel
 

Berlin, Germany
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Cardiac Dimensions Competitors (8)

One of Cardiac Dimensions’s 8 competitors is Valcare Medical, a Venture Capital-Backed company based in Herzliya, Israel.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Valcare Medical Venture Capital-Backed Herzliya, Israel
Biotronik Corporate Backed or Acquired Berlin, Germany
HighLife Venture Capital-Backed Paris, France
TISSIUM Venture Capital-Backed Paris, France
Atricure Formerly VC-backed Mason, OH
You’re viewing 5 of 8 competitors. Get the full list »

Cardiac Dimensions Patents

Cardiac Dimensions Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026236157-A1 Mitral valve cinching device with self-expandable opposing anchors Pending 05-May-2025
WO-2026231735-A1 Tapered stent for coronary sinus perforation occlusion Pending 30-Apr-2025
AU-2023226066-A1 Recollapsible and recapturable devices and methods of use Pending 25-Feb-2022
EP-4482438-A2 Recollapsible and recapturable devices and methods of use Pending 25-Feb-2022
EP-4482438-A4 Recollapsible and recapturable devices and methods of use Pending 25-Feb-2022 A61F2/915
To view Cardiac Dimensions’s complete patent history, request access »

Cardiac Dimensions Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cardiac Dimensions Investors (21)

Investor Name Investor Type Holding Investor Since Participating Rounds
Ally Bridge Group Growth/Expansion Minority
Claret Capital Partners Growth/Expansion Minority
Fortress Investment Group PE/Buyout Minority
Horizon 3 Healthcare Growth/Expansion Minority
Angel (individual) Minority
You’re viewing 5 of 21 investors. Get the full list »

Cardiac Dimensions FAQs

  • When was Cardiac Dimensions founded?

    Cardiac Dimensions was founded in 2001.

  • Where is Cardiac Dimensions headquartered?

    Cardiac Dimensions is headquartered in Kirkland, WA.

  • What is the size of Cardiac Dimensions?

    Cardiac Dimensions has 73 total employees.

  • What industry is Cardiac Dimensions in?

    Cardiac Dimensions’s primary industry is Therapeutic Devices.

  • Is Cardiac Dimensions a private or public company?

    Cardiac Dimensions is a Private company.

  • What is Cardiac Dimensions’s current revenue?

    The current revenue for Cardiac Dimensions is .

  • How much funding has Cardiac Dimensions raised over time?

    Cardiac Dimensions has raised $361M.

  • Who are Cardiac Dimensions’s investors?

    Ally Bridge Group, Claret Capital Partners, Fortress Investment Group, Horizon 3 Healthcare, and are 5 of 21 investors who have invested in Cardiac Dimensions.

  • Who are Cardiac Dimensions’s competitors?

    Valcare Medical, Biotronik, HighLife, TISSIUM, and Atricure are some of the 8 competitors of Cardiac Dimensions.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process